Michele Aquilano

1.1k total citations
21 papers, 119 citations indexed

About

Michele Aquilano is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Michele Aquilano has authored 21 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Radiation. Recurrent topics in Michele Aquilano's work include Prostate Cancer Treatment and Research (7 papers), Advanced Radiotherapy Techniques (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Michele Aquilano is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Advanced Radiotherapy Techniques (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Michele Aquilano collaborates with scholars based in Italy, United States and Netherlands. Michele Aquilano's co-authors include Lorenzo Livi, Isacco Desideri, Icro Meattini, Lucia Pia Ciccone, Giulio Francolini, Pierluigi Bonomo, Viola Salvestrini, Daniela Greto, Silvia Scoccianti and Gabriele Simontacchi and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Cancers.

In The Last Decade

Michele Aquilano

19 papers receiving 116 citations

Peers

Countries citing papers authored by Michele Aquilano

Since Specialization

Citations

This map shows the geographic impact of Michele Aquilano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Aquilano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Aquilano more than expected).

Fields of papers citing papers by Michele Aquilano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Aquilano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Aquilano. The network helps show where Michele Aquilano may publish in the future.

Co-authorship network of co-authors of Michele Aquilano

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Aquilano. A scholar is included among the top collaborators of Michele Aquilano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Aquilano. Michele Aquilano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A deep learning algorithm to generate synthetic computed tomography images for brain treatments from 0.35 T magnetic resonance imaging 2025 ·Physics and Imaging in Radiation Oncology ·(unknown), (unknown), (unknown), (unknown), Francesco Catucci, Jacopo Lenkowicz, Claudio Votta, Michele Aquilano, Andrea D’Aviero, (unknown), (unknown), (unknown), (unknown), (unknown), Antonio Piras, (unknown), (unknown), Gian Carlo Mattiucci, Davide Cusumano	1
2	Integrating Radiomics and Artificial Intelligence (AI) in Stereotactic Body Radiotherapy (SBRT)/Stereotactic Radiosurgery (SRS): Predictive Tools for Tailored Cancer Care 2025 ·Cancers ·(unknown), Marco Banini, Daniela Greto, Luca Visani, (unknown), Mauro Loi, Michele Aquilano, (unknown), Viola Salvestrini, (unknown), (unknown), (unknown), (unknown), Isacco Desideri	1
3	Systematic review of the tools and outcomes for the assessment of acute radiation dermatitis severity 2025 ·Clinical and Translational Radiation Oncology ·(unknown), (unknown), Tara Behroozian, Samuel Finkelstein, Lauren Kanee, (unknown), (unknown), Michele Aquilano, (unknown), Raymond J. Chan, Edward Chow, Adrian Wai Chan, Jennifer Kwan, Shing Fung Lee, Henry C. Y. Wong, Corina van den Hurk, Mark Trombetta, Julie Ryan Wolf	1
4	The role of sequential PET/CT imaging to predict complete response after definitive chemoradiotherapy for locally advanced squamous cell carcinoma of the anal canal. 2025 ·Journal of Clinical Oncology ·(unknown), Michele Aquilano, Mauro Loi, I. Morelli, (unknown), Pierluigi Bonomo, Alessandra Galardi, Giulio Francolini, (unknown), Monica Mangoni, Icro Meattini, Lorenzo Livi	0
5	A Deep Learning Approach for the Fast Generation of Synthetic Computed Tomography from Low-Dose Cone Beam Computed Tomography Images on a Linear Accelerator Equipped with Artificial Intelligence 2024 ·Applied Sciences ·(unknown), (unknown), Jacopo Lenkowicz, (unknown), Francesco Catucci, (unknown), (unknown), Andrea D’Aviero, Michele Aquilano, (unknown), (unknown), (unknown), (unknown), Antonio Piras, (unknown), (unknown), Gian Carlo Mattiucci, Davide Cusumano	3
6	Barrier Films and Dressings for the Prevention of Acute Radiation Dermatitis: A Systematic Review and Meta-Analysis 2023 ·Supportive Care in Cancer ·Jolien Robijns, Michele Aquilano, (unknown), Saverio Caini, Julie Ryan Wolf, Corina van den Hurk, Mara Beveridge, Henry Lam, Pierluigi Bonomo, Edward Kai‐Hua Chow, Tara Behroozian	11
7	Correction to: Barrier films and dressings for the prevention of acute Radiation dermatitis: A systematic review and meta-analysis 2023 ·Supportive Care in Cancer ·Jolien Robijns, Michele Aquilano, (unknown), Saverio Caini, Julie Ryan Wolf, Corina van den Hurk, Mara Beveridge, Henry Lam, Pierluigi Bonomo, Edward Kai‐Hua Chow, Tara Behroozian	1
8	Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 2022 ·International Journal of Molecular Sciences ·Mauro Loi, (unknown), Michele Aquilano, Daniela Greto, C. Talamonti, Viola Salvestrini, Maria Elena Melica, (unknown), Giulio Francolini, Mariangela Sottili, Costanza Santini, Carlotta Becherini, Domenico Andrea Campanacci, Monica Mangoni, Lorenzo Livi	1
9	Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 2022 ·La radiologia medica ·Giulio Francolini, Beatrice Detti, Vanessa Di Cataldo, (unknown), Michele Aquilano, Andrea Gaetano Allegra, Sara Lucidi, (unknown), Lucia Pia Ciccone, Viola Salvestrini, (unknown), (unknown), Luca Visani, Mauro Loi, Isacco Desideri, Monica Mangoni, Icro Meattini, Lorenzo Livi	5
10	A narrative review of postoperative adjuvant radiotherapy for non-small cell lung cancer 2022 ·Mediastinum ·Emanuela Olmetto, Marco Perna, (unknown), Michele Aquilano, Marco Banini, (unknown), Lorenzo Livi, Vieri Scotti	1
11	Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC 2022 ·Radiation Oncology ·Paolo Borghetti, (unknown), (unknown), Vieri Scotti, Michele Aquilano, Alessio Bruni, Davide Franceschini, Stefano Ursino, Patrizia Ciammella, Gaia Piperno, (unknown), Stefano Maria Magrini	5
12	ARTO trial-(NCT03449719): Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration-resistant prostate cancer undergoing I line treatment with abiraterone acetate. 2022 ·Journal of Clinical Oncology ·Giulio Francolini, Beatrice Detti, Vanessa Di Cataldo, Saverio Caini, A.R. Alitto, Silvana Parisi, (unknown), Alessio Bruni, Gianluca Ingrosso, Giorgia Timon, Andrea Gaetano Allegra, Michele Aquilano, Lucia Pia Ciccone, Viola Salvestrini, (unknown), (unknown), Isacco Desideri, Icro Meattini, Monica Mangoni, Lorenzo Livi	0
13	Impact of COVID-19 on workload burden of a complex radiotherapy facility 2021 ·La radiologia medica ·Giulio Francolini, Isacco Desideri, (unknown), Lucia Pia Ciccone, Viola Salvestrini, (unknown), Michele Aquilano, Daniela Greto, Pierluigi Bonomo, Icro Meattini, Vieri Scotti, Silvia Scoccianti, Gabriele Simontacchi, Lorenzo Livi	17
14	Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 2021 ·Clinical & Experimental Metastasis ·Giulio Francolini, Mauro Loi, Viola Salvestrini, Monica Mangoni, Beatrice Detti, Vanessa Di Cataldo, Michele Aquilano, Pamela Pinzani, Francesca Salvianti, Isacco Desideri, (unknown), (unknown), (unknown), Lucia Pia Ciccone, Sara Lucidi, (unknown), Mariangela Sottili, Icro Meattini, Lorenzo Livi	6
15	Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 2021 ·Clinical Oncology ·Giulio Francolini, Mauro Loi, Vanessa Di Cataldo, Beatrice Detti, (unknown), Laura Masi, (unknown), (unknown), Chiara Bellini, Michele Aquilano, Andrea Gaetano Allegra, (unknown), (unknown), (unknown), (unknown), Lucia Pia Ciccone, Viola Salvestrini, Isacco Desideri, Lorenzo Livi	10
16	ARTO trial (NCT03449719), a randomized phase II trial enrolling oligometastatic castration-resistant prostate cancer patients treated with first-line abiraterone acetate with or without stereotactic body radiation therapy: Preliminary results comprehensive of biochemical outcomes and circulating tumor cells analysis. 2021 ·Journal of Clinical Oncology ·Giulio Francolini, (unknown), Mauro Loi, (unknown), Michele Aquilano, Andrea Gaetano Allegra, (unknown), Viola Salvestrini, Pamela Pinzani, Chiara Bellini, Francesca Salvianti, (unknown), Lucia Pia Ciccone, (unknown), Mariangela Sottili, Vanessa Di Cataldo, Isacco Desideri, Monica Mangoni, Icro Meattini, Lorenzo Livi	5
17	Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719) 2020 ·European Urology Open Science ·Giulio Francolini, (unknown), (unknown), Antonio Bruni, Giovanna Mantini, Stefano Pergolizzi, Paolo Borghetti, Rolando Maria D’Angelillo, Filippo Alongi, (unknown), Ciro Franzese, A. Tagliagambe, (unknown), Michele Aquilano, (unknown), Viola Salvestrini, Lucia Pia Ciccone, (unknown), Lorenzo Livi	3
18	Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 2020 ·Supportive Care in Cancer ·Isacco Desideri, Giulio Francolini, Lucia Pia Ciccone, (unknown), Viola Salvestrini, Michele Aquilano, Daniela Greto, Pierluigi Bonomo, Icro Meattini, Vieri Scotti, Silvia Scoccianti, Gabriele Simontacchi, Lorenzo Livi	17
19	Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer 2020 ·Clinical Breast Cancer ·Ivica Ratoša, (unknown), (unknown), (unknown), Luca Dominici, Michele Aquilano, (unknown), Isacco Desideri, Domen Ribnikar, Tanja Marinko, Lorenzo Livi, Icro Meattini	21
20	Preliminary results of a prospective assessment of androgen receptor splice variants in mCRPC patients undergoing androgen receptor targeted agents. 2020 ·Journal of Clinical Oncology ·Giulio Francolini, Mauro Loi, (unknown), Monica Mangoni, Isacco Desideri, (unknown), Lucia Pia Ciccone, Michele Aquilano, Pamela Pinzani, Francesca Salvianti, Sara Lucidi, (unknown), (unknown), (unknown), Mariangela Sottili, Lorenzo Livi	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact